Vantage logo

The trigger for a Seagen buyout

Seagen is vulnerable to takeover, but whether a deal happens – and at what price – depends on at least one catalyst.

Vantage logo

Epizyme accepts reality

Dire market conditions combine with a loan overhang and investor desertion to force Epizyme's hand in a low-ball takeout.

Vantage logo

To buy or build blockbusters?

A look at blockbuster origins shows the role of external innovation, but more of these huge franchises are in the hands of their inventors than ever before.